Yahoo
NSE - Delayed Quote INR

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS)

217.42 +0.03 (+0.01%)
At close: November 9 at 3:30:02 PM GMT+5:30
View in AlphaSpace Currency in INR All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
3/31/2026
3/31/2025
3/31/2024
3/31/2023
Cash Flow from Operating Activities, Indirect
476,020 468,120 551,130 351,660 466,550
Cash Flow from Investing Activities
180,540 -356,490 -451,470 -245,480 -576,710
Cash Flow from Financing Activities
-592,160 -121,490 -116,980 -89,110 -4,570
Cash and Cash Equivalents, End of Period
191,320 100,420 110,280 127,600 110,530
Cash Flow, Supplemental
Free Cash Flow to Firm
506,998.77 487,821.83 491,499.38 291,493.44 366,414.12
Capital Expenditure, Calculated
1,270 1,480 3,480 2,480 3,180
Issuance of Capital Stock
87,200 66,290 33,910 56,350 0
Repurchase of Capital Stock
-313,940 0 0 0 0
Free Cash Flow to Cash Flow from Operating Activities
1.00 1.00 0.99 0.99 0.99
3/31/2023 - 7/1/2002

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: